Department of Clinical Physiology and Nuclear Medicine, Bispebjerg and Frederiksberg Hospital, University Hospital of Copenhagen, Copenhagen, Denmark
Search for other papers by Meena Asmar in
Google Scholar
PubMed
Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, University Hospital of Copenhagen, Copenhagen, Denmark
Search for other papers by Ali Asmar in
Google Scholar
PubMed
Search for other papers by Lene Simonsen in
Google Scholar
PubMed
Department of Geriatrics, Bispebjerg and Frederiksberg Hospital, University Hospital of Copenhagen, Copenhagen, Denmark
Search for other papers by Flemming Dela in
Google Scholar
PubMed
Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Juul Holst in
Google Scholar
PubMed
Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Bülow in
Google Scholar
PubMed
intake ( 10 ). GIP is well founded as an incretin hormone potentiating insulin release from β-cells in healthy humans ( 10 , 11 , 12 ). In addition to its insulinotropic effects, we have previously shown that GIP infusion during physiological
Search for other papers by Nicolai J Wewer Albrechtsen in
Google Scholar
PubMed
NNF Center for Basic Metabolic Research and Department of Biomedical Sciences, Department of Science, Faculty of Health Science, University of Copenhagen, Blegdamsvej 3B, 12.2, DK‐2200 Copenhagen N, Denmark
Search for other papers by Monika J Bak in
Google Scholar
PubMed
Search for other papers by Bolette Hartmann in
Google Scholar
PubMed
Search for other papers by Louise Wulff Christensen in
Google Scholar
PubMed
Search for other papers by Rune E Kuhre in
Google Scholar
PubMed
Search for other papers by Carolyn F Deacon in
Google Scholar
PubMed
Search for other papers by Jens J Holst in
Google Scholar
PubMed
Holst JJ . Targeting the intestinal L-cell for obesity and type 2 diabetes treatment . Expert Review of Endocrinology & Metabolism 2014 9 61 – 72 . ( doi:10.1586/17446651.2014.862152 ). 3 Holst JJ . Incretin hormones and the satiation signal
Institute of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Ulrik Ø Andersen in
Google Scholar
PubMed
Institute of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Dijana Terzic in
Google Scholar
PubMed
Institute of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Centre for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Nicolai Jacob Wewer Albrechtsen in
Google Scholar
PubMed
Institute of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Peter Dall Mark in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Peter Plomgaard in
Google Scholar
PubMed
Search for other papers by Jens F Rehfeld in
Google Scholar
PubMed
Search for other papers by Finn Gustafsson in
Google Scholar
PubMed
Institute of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens P Goetze in
Google Scholar
PubMed
( 23 ). While it remains unresolved exactly how sacubitril/valsartan improves the glycemic control, several mechanisms have been suggested including increased plasma concentrations of the incretin hormone GLP-1 ( 23 ). We have recently reported that
Search for other papers by Shenghe Luo in
Google Scholar
PubMed
Department of Cardiology, Yanbian University Hospital, Yanji, China
Search for other papers by Yunhui Zuo in
Google Scholar
PubMed
Search for other papers by Xiaotian Cui in
Google Scholar
PubMed
Search for other papers by Meiping Zhang in
Google Scholar
PubMed
Search for other papers by Honghua Jin in
Google Scholar
PubMed
Search for other papers by Lan Hong in
Google Scholar
PubMed
Introduction Glucagon-like peptide 1 (GLP-1) is one of the components of incretin, which can regulate the metabolism of the body and has a wide range of pharmacological effects ( 1 , 2 ). GLP-1R agonists like as liraglutide are currently
Danish Diabetes Academy, Odense University Hospital, Odense, Denmark
Search for other papers by Charlotte Janus in
Google Scholar
PubMed
Search for other papers by Dorte Vistisen in
Google Scholar
PubMed
Department of Public Health, Research Unit of Epidemiology, Aarhus University, Aarhus, Denmark
Search for other papers by Hanan Amadid in
Google Scholar
PubMed
Department of Public Health, Research Unit of Epidemiology, Aarhus University, Aarhus, Denmark
Steno Diabetes Center Aarhus, Aarhus, Denmark
Search for other papers by Daniel R Witte in
Google Scholar
PubMed
Search for other papers by Torsten Lauritzen in
Google Scholar
PubMed
Search for other papers by Søren Brage in
Google Scholar
PubMed
Search for other papers by Anne-Louise Bjerregaard in
Google Scholar
PubMed
Search for other papers by Torben Hansen in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens J Holst in
Google Scholar
PubMed
National Institute of Public Health, University of Southern Denmark, Odense, Denmark
Search for other papers by Marit E Jørgensen in
Google Scholar
PubMed
Search for other papers by Oluf Pedersen in
Google Scholar
PubMed
Search for other papers by Kristine Færch in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Signe S Torekov in
Google Scholar
PubMed
for premature mortality ( 4 ). Glucagon-like peptide-1 (GLP-1) is a peptide hormone secreted from intestinal L-cells upon meal intake ( 5 ). GLP-1 stimulates insulin secretion in a glucose-dependent manner – as part of ‘the incretin effect’ – being
Search for other papers by Jonathan Hazlehurst in
Google Scholar
PubMed
Search for other papers by Bernard Khoo in
Google Scholar
PubMed
Department of Medicine, Copenhagen University Hospital – Amager and Hvidovre, Hvidovre, Denmark
Search for other papers by Carolina Brito Lobato in
Google Scholar
PubMed
Search for other papers by Ibiyemi Ilesanmi in
Google Scholar
PubMed
Search for other papers by Sally Abbott in
Google Scholar
PubMed
Search for other papers by Tin Chan in
Google Scholar
PubMed
Search for other papers by Sanesh Pillai in
Google Scholar
PubMed
Search for other papers by Kate Maslin in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, UK
Search for other papers by Sanjay Purkayastha in
Google Scholar
PubMed
Search for other papers by Barbara McGowan in
Google Scholar
PubMed
Search for other papers by Rob Andrews in
Google Scholar
PubMed
Search for other papers by Eveleigh Nicholson in
Google Scholar
PubMed
Search for other papers by Katherine McCullough in
Google Scholar
PubMed
Search for other papers by Lorraine Albon in
Google Scholar
PubMed
Search for other papers by Rachel Batterham in
Google Scholar
PubMed
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Search for other papers by Shareen Forbes in
Google Scholar
PubMed
Search for other papers by Gavin Bewick in
Google Scholar
PubMed
Search for other papers by Tricia M-M Tan in
Google Scholar
PubMed
clarification were added with the assistance of BK, TT and CBL after peer review. Pathophysiology of PBH The exact pathophysiology of PBH is unknown, but the dynamic interaction of food absorption, incretin, and insulin secretion is thought to play a
Search for other papers by Ann-Kristin Picke in
Google Scholar
PubMed
Search for other papers by Graeme Campbell in
Google Scholar
PubMed
Division of Bone and Mineral Diseases, Washington University in St Louis, St Louis, Missouri, USA
Search for other papers by Nicola Napoli in
Google Scholar
PubMed
Search for other papers by Lorenz C Hofbauer in
Google Scholar
PubMed
Search for other papers by Martina Rauner in
Google Scholar
PubMed
↑ ↓ ↑* ↑ ↓/= ↓/= ↑/= ↓/= Thiazolidinediones ↓ ↑ ↓/= ? ↓/=/↑ ↑/=/↑ ↓/= ↑/= Insulin ↑ = ↑/= ↑ = = = ↑/= Sulphonyl urea ↑ ↓ ↑ ? ↑/= ↓/= = ↑ Incretins ↓ ↓ ↑/= ? ↓/= ↓/= ↑/= ↓/= SGLT2
Search for other papers by Benjamin Paul Green in
Google Scholar
PubMed
Search for other papers by Javier Thomas Gonzalez in
Google Scholar
PubMed
Search for other papers by Kevin Thomas in
Google Scholar
PubMed
Search for other papers by Emma Stevenson in
Google Scholar
PubMed
Search for other papers by Penny Louise Sheena Rumbold in
Google Scholar
PubMed
satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal . American Journal of Clinical Nutrition 2009 90 1236 – 1243 . ( doi:10.3945/ajcn.2009.28095 ). 10 Atkinson G Nevill A
Search for other papers by Julia Otten in
Google Scholar
PubMed
Region Jönköping County, Jönköping, Sweden
Search for other papers by Andreas Stomby in
Google Scholar
PubMed
Search for other papers by Maria Waling in
Google Scholar
PubMed
Search for other papers by Elin Chorell in
Google Scholar
PubMed
Search for other papers by Mats Ryberg in
Google Scholar
PubMed
Search for other papers by Michael Svensson in
Google Scholar
PubMed
Search for other papers by Jens Juul Holst in
Google Scholar
PubMed
Search for other papers by Tommy Olsson in
Google Scholar
PubMed
. ( https://doi.org/10.1210/jcem-64-1-106 ) 18 Knop FK Vilsboll T Madsbad S Holst JJ Krarup T . Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in
Search for other papers by Alexis Sudlow in
Google Scholar
PubMed
Search for other papers by Carel W le Roux in
Google Scholar
PubMed
Search for other papers by Dimitri J Pournaras in
Google Scholar
PubMed
by a powerful incretin effect resulting in increased GLP-1, PYY and alterations in bile acid metabolism ( 32 , 33 ). The fact that it is an infrequently performed procedure reflects that it is not only technically challenging but also associated with